BofA/Merrill Lynch upgraded Abbott Labs (NYSE: ABT) from Neutral to Buy with a price target of $52.00 (from $50.00).Analyst Bob ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE